Human metapneumovirus infection in a cohort of young asymptomatic subjects

Section of Microbiology, Department of Pharmaco-Biology, University of Calabria, Rende (Cosenza), Italy.
The New Microbiologica: official journal of the Italian Society for Medical Virology (SIVIM) (Impact Factor: 1.78). 07/2009; 32(3):297-301.
Source: PubMed


Human metapneumovirus (HMPV) is a recently described cause of respiratory infection. The purpose of this study was to to further the available information on the circulation of HMPV among young asymptomatic subjects. The epidemiology of HMPV was examined in a cohort of 73 university students during a winter season by using polymerase chain reaction. HPMV was detected in 3/73 (4.1%) asymptomatic subjects. Phylogenetic analysis has shown that circulating viruses belonged to different HMPV sublineages. Our findings indicate that asymptomatic carriage of HMPV might be a neglected source of viral transmission in the community.

Download full-text


Available from: Paola Apostoli
  • Source
    • "Primarily at risk of severe HMPV-related disease are infants, immunocompromised patients and the elderly (Boivin et al., 2002; O'Gorman et al., 2006; Sivaprakasam et al., 2007; van den Hoogen et al., 2004b, 2003; Williams et al., 2005). Infection with HMPV can be both symptomatic and asymptomatic (Bruno et al., 2009). Clinical manifestations of symptomatic HMPV are indistinguishable from those of human respiratory syncytial virus (HRSV) and range from mild upper respiratory tract infection to severe disease requiring hospitalisation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: First identified in 2001, human metapneumovirus (HMPV) is a novel pathogen and causative agent of acute respiratory tract infection. Re-infection with HMPV is common, and currently there is no available vaccine against HMPV infection. Two genotypes of HMPV have been identified, A and B, both of which can be divided further into at least two distinct sub-genotypes. Here we report the results of the first study to investigate the genetic variability of HMPV strains circulating within Cambodia. The overall incidence of HMPV infection amongst an all-ages population of patients hospitalised with ALRI in Cambodia during 3 consecutive years, between 2007 and 2009, was 1.7%. The incidence of HMPV infection was highest amongst children less than 5 years of age, with pneumonia or bronchopneumonia the most frequent clinical diagnoses across all age groups. The incidence of HMPV infection varied annually. As anticipated, genetic diversity was low amongst the conserved F gene sequences but very high amongst G gene sequences, some strains sharing as little as 56.3% and 34.2% homology at the nucleotide and amino acid levels, respectively. Simultaneous co-circulation of strains belonging to the HMPV sub-genotypes B1, B2 and lineage A2b, amongst patients recruited at 2 geographically distinct provincial hospitals, was detected. Sub-genotype B2 strains were responsible for the majority of the infections detected, and a significant (p=0.013) association between infection with lineage A2b strains and disease severity was observed.
    Full-text · Article · Feb 2011 · Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this paper, we propose to miniaturize an argon (Ar) GFIS at micron or sub-micron scale. The source can be operated at room temperature and high pressure (100 mbar) and voltages below 140 Volts (i.e the minimum in the Paschen curve for Ar-gas) to avoid Ar gas discharges.
    No preview · Article · Jan 2003
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Human metapneumovirus (hMPV) has been recognized as an important respiratory pathogen. Due to its relatively recent discovery, only limited information is available on the relationship between hMPV and type I interferons (IFN). This study was designed to determine whether in vitro hMPV is sensitive to the antiviral activity of IFN-β, leukocyte IFN-α, and several IFN-α subtypes in a human Hep-2 cell line. The results showed that 50% inhibitory concentration values against hMPV for the various type I IFN preparations were significantly higher than those against the IFN-sensitive vesicular stomatitis virus, and some IFN-α subtypes appeared to be more active against hMPV than others, with IFN-α subtypes 5, 6, 8, and 10 being the most potent, and IFN-α2, 17, and 21 the least potent. The results show that hMPV grown in Hep-2 is partially resistant to the antiviral activity of type I IFNs. Additional studies are required to understand whether and to what extent the relatively low sensitivity of hMPV to IFNs influences the clinical outcomes of infected individuals.
    Full-text · Article · Apr 2011 · Viral immunology
Show more